Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Park Ha Biological Technology ( (BYAH) ) just unveiled an announcement.
On March 16, 2026, Park Ha Biological Technology Co., Ltd., a China-based life sciences company listed in the United States as a foreign private issuer, reported a change in its board composition. The company, headquartered in Wuxi’s International Life Science Innovation Campus, remains subject to U.S. securities disclosure requirements under Form 20-F.
On that same date, director Li Wang resigned from the board of Park Ha Biological Technology, with the company stating that her departure did not stem from any disagreement over its operations, policies, or procedures. The resignation, confirmed by CEO and chairperson Xiaoqiu Zhang in a regulatory filing, suggests a routine governance change rather than an indication of internal conflict, limiting immediate implications for shareholders or corporate strategy.
More about Park Ha Biological Technology
Park Ha Biological Technology Co., Ltd. is a China-based life sciences company headquartered in Wuxi, Jiangsu Province, operating from the Wuxi International Life Science Innovation Campus. The company is listed in the United States as a foreign private issuer under the Securities Exchange Act of 1934 and files its annual reports on Form 20-F.
Average Trading Volume: 303,535
Technical Sentiment Signal: Strong Sell
Current Market Cap: $3.86M
Find detailed analytics on BYAH stock on TipRanks’ Stock Analysis page.